<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT03263962</url>
  </required_header>
  <id_info>
    <org_study_id>20170016069</org_study_id>
    <nct_id>NCT03263962</nct_id>
  </id_info>
  <brief_title>Canrenone Effects on Cardiovascular Mortality in Patients With Congestive Heart Failure (the Coffee-it Study)</brief_title>
  <acronym>THE COFFEE-IT</acronym>
  <official_title>Canrenone Effects on Cardiovascular Mortality in Patients With Congestive Heart Failure: the Coffee-it Study</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>University of Pavia</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>University of Pavia</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      To evaluate canrenone effects compared to other therapies on cardiovascular mortality in
      patients with congestive heart failure and preserved systolic function after 12 years of
      evaluation.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      The investigators will verify patients with cardiac heart failure (CHF) and preserved
      systolic function and each patient must have all clinical evaluation through basal
      measurements of blood pressure, heart rate, biochemical tests, and color Doppler
      echocardiographic parameters for at least 12 years.

      The investigators will evaluate the effects of an aldosterone antagonist as canrenone
      compared to a group without canrenone and the investogators will verify how many patients
      reported cardiovascular mortality or will survive.
    </textblock>
  </detailed_description>
  <overall_status>Completed</overall_status>
  <start_date type="Actual">July 13, 2017</start_date>
  <completion_date type="Actual">November 30, 2017</completion_date>
  <primary_completion_date type="Actual">September 10, 2017</primary_completion_date>
  <study_type>Observational</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Cohort</observational_model>
    <time_perspective>Retrospective</time_perspective>
  </study_design_info>
  <primary_outcome>
    <measure>Progression of CHF</measure>
    <time_frame>12 years</time_frame>
    <description>Echocardiografic data</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Haemodynamic data</measure>
    <time_frame>12 years</time_frame>
    <description>Systolic blood pressure (SBP, Diastolic blood pressure (DBP), Heart rate (HR)</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Metabolic data</measure>
    <time_frame>12 years</time_frame>
    <description>fasting plasma glucose (FPG), total cholesterol (TC), HDL-cholesterol (HDL-C), triglycerides (Tg), LDL-cholesterol (LDL-C), lipoprotein (a) [Lp(a)],</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Renal function</measure>
    <time_frame>12 years</time_frame>
    <description>Sodium, Potassium, Creatinine, Uric acid</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Endocrine data</measure>
    <time_frame>12 years</time_frame>
    <description>Aldosterone, Plasma brain natriuretic peptide (BNP), Plasma renin activity (PRA)</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Cardiovascular mortality</measure>
    <time_frame>12 years</time_frame>
    <description>Register data</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Survival</measure>
    <time_frame>12 years</time_frame>
    <description>Register data</description>
  </primary_outcome>
  <number_of_groups>2</number_of_groups>
  <enrollment type="Actual">502</enrollment>
  <condition>Cardiac Heart Failure Patients</condition>
  <arm_group>
    <arm_group_label>With canrenone</arm_group_label>
    <description>Patients with canrenone</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Without canrenone</arm_group_label>
    <description>Patients without canrenone</description>
  </arm_group>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Canrenone</intervention_name>
    <description>Evaluation of canrenone therapy in patients with CHF</description>
    <arm_group_label>With canrenone</arm_group_label>
  </intervention>
  <eligibility>
    <study_pop>
      <textblock>
        Patients with CHF and preserved systolic function with or without an aldosterone antagonist
        as canrenone.
      </textblock>
    </study_pop>
    <sampling_method>Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  patients with CHF

          -  preserved systolic function (FE ≥ 45%)

        Exclusion Criteria:

          -  severe hypertension identified by blood pressure ≥180/110 mmHg

          -  patients with impaired systolic function (FE &lt; 45%)

          -  history of active hepatitis or cirrhosis

          -  impaired renal function

          -  hyperpotassemia

          -  diabetes
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>90 Years</maximum_age>
  </eligibility>
  <location>
    <facility>
      <name>IRCCS Policlinico San Matteo</name>
      <address>
        <city>Pavia</city>
        <zip>27100</zip>
        <country>Italy</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>Italy</country>
  </location_countries>
  <verification_date>February 2018</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>August 23, 2017</study_first_submitted>
  <study_first_submitted_qc>August 23, 2017</study_first_submitted_qc>
  <study_first_posted type="Actual">August 28, 2017</study_first_posted>
  <last_update_submitted>February 1, 2018</last_update_submitted>
  <last_update_submitted_qc>February 1, 2018</last_update_submitted_qc>
  <last_update_posted type="Actual">February 5, 2018</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>University of Pavia</investigator_affiliation>
    <investigator_full_name>Giuseppe Derosa</investigator_full_name>
    <investigator_title>MD, PhD, FESC</investigator_title>
  </responsible_party>
  <keyword>CHF</keyword>
  <keyword>Canrenone</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Heart Failure</mesh_term>
  </condition_browse>
  <intervention_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Canrenone</mesh_term>
  </intervention_browse>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

